X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
carcinoma, non-small-cell lung - drug therapy (5) 5
chemotherapy (5) 5
humans (5) 5
index medicus (5) 5
lung cancer, non-small cell (5) 5
lung neoplasms - drug therapy (5) 5
oncology (5) 5
adult (4) 4
aged (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
cancer (4) 4
care and treatment (4) 4
female (4) 4
male (4) 4
middle aged (4) 4
antimitotic agents (3) 3
antineoplastic agents (3) 3
cancer patients (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
clinical trials (3) 3
hematology, oncology and palliative medicine (3) 3
lung neoplasms - mortality (3) 3
oncology, experimental (3) 3
product development (3) 3
research (3) 3
aged, 80 and over (2) 2
analysis (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
blockade (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
cetuximab (2) 2
disease-free survival (2) 2
growth-factor receptor (2) 2
iii trial (2) 2
lung cancer (2) 2
lung neoplasms - pathology (2) 2
medical colleges (2) 2
non-small cell lung carcinoma (2) 2
patient outcomes (2) 2
patients (2) 2
proportional hazards models (2) 2
survival analysis (2) 2
taxoids - adverse effects (2) 2
tumors (2) 2
1900-1969 (1) 1
abridged index medicus (1) 1
adolescent (1) 1
anniversary volumes (1) 1
anti-pd-1 antibody (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibody cetuximab (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
apoptosis (1) 1
article (1) 1
asian continental ancestry group (1) 1
b7-h1 antigen - metabolism (1) 1
besseler, heinrich (1) 1
besseler, heinrich, 1900-1969 (1) 1
biomarkers (1) 1
biomarkers, tumor - antagonists & inhibitors (1) 1
biomarkers, tumor - metabolism (1) 1
body weight (1) 1
brazil (1) 1
breast-cancer (1) 1
carboplatin (1) 1
carcinoma (1) 1
carcinoma, non-small-cell lung - enzymology (1) 1
carcinoma, squamous cell - drug therapy (1) 1
carcinoma, squamous cell - mortality (1) 1
carcinomas (1) 1
cell survival (1) 1
chemoradiotherapy (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
clinical decision making (1) 1
combined modality therapy (1) 1
commemorative volumes (1) 1
comparative analysis (1) 1
continuity (1) 1
data analysis (1) 1
data processing (1) 1
death (1) 1
diagnosis (1) 1
digestive system diseases (1) 1
docetaxel (1) 1
dosage and administration (1) 1
dose-escalation (1) 1
double-blind method (1) 1
drug dosages (1) 1
durvalumab (1) 1
endothelium (1) 1
epidermal growth factor (1) 1
estrogen-receptor (1) 1
europe (1) 1
exanthema - chemically induced (1) 1
festschriften (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 7, pp. 619 - 626
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 33 - 42
Summary Background Findings from the phase 3 First-Line ErbituX in lung cancer (FLEX) study showed that the addition of cetuximab to first-line chemotherapy... 
Hematology, Oncology and Palliative Medicine | BREAST-CANCER | BIOMARKERS | GROWTH-FACTOR RECEPTOR | OVEREXPRESSION | ONCOLOGY | PROTEIN EXPRESSION | IN-SITU HYBRIDIZATION | CARCINOMAS | GENE AMPLIFICATION | ESTROGEN-RECEPTOR | III TRIAL | Immunohistochemistry | Lung Neoplasms - drug therapy | Up-Regulation | Prospective Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Patient Selection | Young Adult | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Time Factors | Vinblastine - analogs & derivatives | Aged, 80 and over | Biomarkers, Tumor - metabolism | Brazil | Adult | Female | Biomarkers, Tumor - antagonists & inhibitors | Cetuximab | Odds Ratio | Republic of Korea | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - enzymology | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Care and treatment | Patient outcomes | Oncology, Experimental | Research | Lung cancer, Non-small cell | Antineoplastic agents | Antimitotic agents | Cancer patients | Chemotherapy | Product development | Tumors | Cancer
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 2, pp. 123 - 135
Journal Article
Der Onkologe, ISSN 0947-8965, 12/2018, Volume 24, Issue 12, pp. 974 - 982
Basierend auf der ausgeprägten Heterogenität der Patientengruppen im Stadium III des nichtkleinzelligen Lungenkarzinoms („non-small-cell lung cancer“, NSCLC) –... 
Prognose | Prognosis | Clinical decision making | Medicine & Public Health | Neoplasm staging | Durvalumab | Klinische Entscheidungsfindung | Radiochemotherapie | Oncology | Chemoradiotherapy | Tumorklassifikation
Journal Article
Seminars in Oncology, ISSN 0093-7754, 02/1992, Volume 19, Issue 1, pp. 40 - 48
In recent years, ifosfamide has proven to be one of the most effective cytostatic drugs in the treatment of non-small cell lung cancer. Single-agent studies... 
Lung Neoplasms - drug therapy | Ifosfamide - therapeutic use | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Combined Modality Therapy | Carcinoma, Non-Small-Cell Lung - drug therapy
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.